Evidence map›Paper›PMID 41170464›Full record

ArticleFrontiers in oncology2025

Developing organ dysfunction diagnostic criteria for children with cancer and post-hematopoietic cell transplantation: protocol of systematic review.

Michael Bashir, Sayeda Islam, Jordan Wrigley, Anita Arias, Roelie M Wösten-van Asperen, Kimberly K Kertis, Melissa M Hudson, Courtney M Rowan, Aimee C Talleur, Joshua Wolf and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Michael BashirDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States.
Sayeda IslamWashington University in St. Louis School of Medicine, St. Louis, MO, United States.
Jordan WrigleyBiomedical Library, St. Jude Children's Research Hospital, Memphis, TN, United States.
Anita AriasDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States.
Roelie M Wösten-van AsperenDepartment of Pediatric Intensive Care, University Medical Centre Utrecht, Wilhelmina Children's Hospital, Utrecht, Netherlands.
Kimberly K KertisBiomedical Library, St. Jude Children's Research Hospital, Memphis, TN, United States.
Melissa M HudsonDivision of Cancer Survivorship, Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, United States.
Courtney M RowanDepartment of Pediatrics, Division of Critical Care, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, United States.
Aimee C TalleurDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, United States.
Joshua WolfDepartment of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN, United States.
Benjamin OelkersDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States.
Melissa R Hines *Division of Critical Care, Department of Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States.
Asya Agulnik *Department of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, United States.

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
NCI NIH HHS P30 CA021765
6 · The paper itself

Abstract

Background: The Pediatric Organ Dysfunction Information Update Mandate (PODIUM) proposed consensus criteria to define organ dysfunction in critically ill children. However, utilization of the PODIUM criteria in pediatric oncology patients and those who have received hematopoietic cell transplantation or cellular therapy (post-HCT/CAR) may inaccurately classify organ dysfunction in these patients due to differences in organ dysfunction etiology, pathophysiology, and risk factors for adverse outcomes. To address this gap, we report a study protocol to systematically review the performance of the PODIUM criteria for pediatric cancer and/or those treated with HCT and determine if adjustments are needed. Objective: The objectives of this study will be to [1] identify evidence-based criteria for organ dysfunction predicting adverse outcomes among pediatric oncology and post-HCT patients, [2] use these findings to inform adapted consensus criteria (PODIUM-Onc) for organ dysfunction tailored to this high-risk population through a multidisciplinary modified Delphi process, and [3] describe knowledge gaps to guide future research. Data source and search strategy: We will perform a systematic literature review of studies published since January 1, 2004, using the following databases: MEDLINE (via PubMed), CINAHL (via EBSCO), EMBASE (via Elsevier), and Web of Science (via Clarivate). Search results will be filtered using a pediatric search hedge and further refined to children (0 to 21 years old) during or up to 1 year after treatment for cancer or HCT/CAR for malignancy. Publications without original data (e.g., comments, editorials, letters, notes, conference materials), studies with ≤ 10 patients, and those preceding January 1, 2004, will be excluded. Study selection: We will include original studies in any language published since January 1, 2004, that meet all eligibility criteria and for which a full text is available. Data extraction: Data extraction will include information related to study characteristics, hospital characteristics, underlying population characteristics, patient population characteristics, and outcomes. Data synthesis: We will extract and report data on the study, hospital, and patient characteristics, outcomes, and risk of bias. Conclusion: By systematically reviewing and analyzing organ-specific factors associated with patient outcomes and synthesizing these findings through a modified Delphi consensus process, we aim to create consensus criteria that will be clinically relevant for pediatric oncology patients and HCT patients. These criteria will provide a foundation to guide clinical care and to support future research in this vulnerable patient population.

Indexed as

critical carehematopoietic (stem cell) transplant (HSCT)multiorgan dysfunctionpediatric oncologyPICU (pediatric intensive care unit)protocol papersystematic reviews

Identifiers

PMID41170464
PMCPMC12568018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.